Study of intensive pediatric pharmacovigilance of monoclonal antibody nimotuzumab for the treatment of malignant glioma tumors
Latest Information Update: 14 Oct 2020
At a glance
- Drugs Nimotuzumab (Primary) ; Carboplatin; Cisplatin; Cyclophosphamide; Procarbazine
- Indications Glioma
- Focus Adverse reactions
- Acronyms NIMOPED
- 05 Oct 2020 Status changed from active, no longer recruiting to completed.
- 25 Aug 2016 New trial record